These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9412619

  • 1. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation.
    Sato Y, Honda Y, Kunoh H, Oizumi K.
    Stroke; 1997 Dec; 28(12):2390-4. PubMed ID: 9412619
    [Abstract] [Full Text] [Related]

  • 2. Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation.
    Sato Y, Honda Y, Jun I.
    Cerebrovasc Dis; 2010 Dec; 29(1):73-78. PubMed ID: 19907166
    [Abstract] [Full Text] [Related]

  • 3. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients.
    Sato Y, Honda Y, Kuno H, Oizumi K.
    Bone; 1998 Sep; 23(3):291-6. PubMed ID: 9737352
    [Abstract] [Full Text] [Related]

  • 4. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H, Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato S, Kario K, Kitazono T, Toyoda K, SAMURAI Study Investigators.
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [Abstract] [Full Text] [Related]

  • 5. Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation.
    Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, Kitasato L, Hashimoto T, Kameda R, Meguro K, Shimohama T, Tojo T, Ako J.
    Heart Vessels; 2017 Aug; 32(8):977-982. PubMed ID: 28233091
    [Abstract] [Full Text] [Related]

  • 6. Vitamin K deficiency and osteopenia in disuse-affected limbs of vitamin D-deficient elderly stroke patients.
    Sato Y, Tsuru T, Oizumi K, Kaji M.
    Am J Phys Med Rehabil; 1999 Aug; 78(4):317-22. PubMed ID: 10418836
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW.
    J Am Coll Cardiol; 2013 Feb 12; 61(6):651-8. PubMed ID: 23391196
    [Abstract] [Full Text] [Related]

  • 11. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P.
    Int J Stroke; 2017 Aug 12; 12(6):589-596. PubMed ID: 28730948
    [Abstract] [Full Text] [Related]

  • 12. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
    Wu S, Xie S, Xu Y, Que D, Yau TO, Wang L, Huang Y.
    J Clin Nurs; 2019 May 12; 28(9-10):1839-1846. PubMed ID: 30667111
    [Abstract] [Full Text] [Related]

  • 13. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M.
    J Am Heart Assoc; 2017 Jul 18; 6(7):. PubMed ID: 28720644
    [Abstract] [Full Text] [Related]

  • 14. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.
    Am J Cardiol; 2017 May 15; 119(10):1590-1595. PubMed ID: 28363354
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.
    Am Heart J; 2017 Jul 15; 189():40-47. PubMed ID: 28625380
    [Abstract] [Full Text] [Related]

  • 16. Stroke prevention in atrial fibrillation.
    Freedman B, Potpara TS, Lip GY.
    Lancet; 2016 Aug 20; 388(10046):806-17. PubMed ID: 27560276
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY, GLORIA-AF Investigators.
    Europace; 2016 Sep 20; 18(9):1308-18. PubMed ID: 27335063
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia.
    Wang CL, Wu VC, Lee CH, Kuo CF, Chen YL, Chu PH, Chen SW, Wen MS, See LC, Chang SH.
    J Thromb Thrombolysis; 2019 May 20; 47(4):512-519. PubMed ID: 30565148
    [Abstract] [Full Text] [Related]

  • 19. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
    Kampouraki E, Kamali F.
    Expert Rev Clin Pharmacol; 2017 Aug 20; 10(8):789-797. PubMed ID: 28635328
    [Abstract] [Full Text] [Related]

  • 20. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B, Pandya B, Cohen J, Zhang M, Lopes RD, Garcia DA, Sherwood MW, Spyropoulos AC.
    Circulation; 2018 Oct 02; 138(14):1402-1411. PubMed ID: 29794081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.